Progress in Vaccinology: Progress in Vaccinology, cartea 2
Autor G. P. Talwaren Limba Engleză Paperback – 27 sep 2011
Preț: 626.52 lei
Preț vechi: 737.07 lei
-15%
Puncte Express: 940
Carte tipărită la comandă
Livrare economică 31 august-14 septembrie
Livrare prin curier în România Termenul estimat este afișat lângă disponibilitate.
Transport gratuit pentru acest produs Plată online sau ramburs, în funcție de opțiunile comenzii.
Retur gratuit în 14 zile Comandă securizată și suport în română.
Specificații
ISBN-13: 9781461281320
ISBN-10: 1461281326
Pagini: 528
Ilustrații: XX, 483 p.
Dimensiuni: 155 x 235 x 28 mm
Greutate: 0.73 kg
Ediția:Softcover reprint of the original 1st ed. 1989
Editura: Springer
Colecția Springer
Seria Progress in Vaccinology
Locul publicării:New York, NY, United States
ISBN-10: 1461281326
Pagini: 528
Ilustrații: XX, 483 p.
Dimensiuni: 155 x 235 x 28 mm
Greutate: 0.73 kg
Ediția:Softcover reprint of the original 1st ed. 1989
Editura: Springer
Colecția Springer
Seria Progress in Vaccinology
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
I Opening Remarks.- 1. Vaccinology: The Two Revolutions.- II Public Health Perspective—The Present Scene.- 2. Vaccinology and the Goal of Health for All.- 3. Toward Universal Immunization: 1990.- 4. New and Improved Techniques for Vaccine Production.- 5. Transfer of Vaccine Production to the Developing World: Rabies Vaccine.- 6. Policy for Developing Countries for Storage, Distribution, and Use of Essential Vaccines for Immunoprophylaxis.- III Environmental Factors Modulating The Efficacy of The Vaccine.- 7. Immunity in Tuberculosis: Environmental Versus Intrinsic Factors Modulating the Immune Responsiveness to Mycobacteria.- 8. Geographic Variation in Vaccine Efficacy: The Polio Experience.- IV Hepatitis.- 9. Molecular Immunology of Viral Antigens in Hepatitis B Vaccinations.- 10. Biologic Significance of Pre-S Antigen and Anti-Pre-S Antibodies in Hepatitis B Virus Infection.- 11. Enterically Transmitted Hepatitis Viruses: Prospects for Control.- 12. Immunological Characterization of a Viral Agent Involved in Epidemic and Sporadic Non-A Non-B Hepatitis.- V Gastrointestinal Infections.- 13. Attenuated Oral Typhoid Vaccine Ty 21a.- 14. Oral B Subunit—Whole Cell Vaccine Against Cholera: From Basic Research to Successful Field Trial.- 15. Prospects of Immunization Against Cholera by Adhesive Antigen.- 16. Protective Antigens of Vibrio cholerae.- 17. Rationale for the Development of a Rotavirus Vaccine for Infants and Young Children.- 18. Mucosal Immunity in the Gastrointestinal Tract in Relation to ETEC Vaccine Development.- 19. Shigella Vaccines.- 20. DNA Sequence Homology Among Genes of Shigella spp. and Enteroinvasive Escherichia coli...- 21. Mucosal and Acquired Immunity in Giardiasis and Its Relation to Diarrhea and Malabsorption.- 22. Immunology of Entamoebahistolytica in Human and Experimental Hosts.- 23. Molecular Comparisons Among Entamoeba histolytica Strains Using DNA and Protein Profiles.- VI Filariasis.- 24. Importance of Antibody Class in Helminth Infections.- 25. Immunodiagnosis of Filariasis.- VII Veterinary Vaccines.- 26. Development, Production, and Application of Vaccines in Foot-and-Mouth Disease Control in India.- 27. Cell Culture Vaccine Against Bovine Tropical Theileriosis.- VIII Leprosy.- 28. Present Approaches to Immunotherapy and Immunoprophylaxis for Leprosy.- 29. Armadillo-Derived Killed M. leprae: Candidate Vaccine Against Leprosy.- 30. Mycobacterium w: Candidate Vaccine Against Leprosy with Antigens Cross-Reactive with Three Major Protein Antigens of Mycobacterium leprae.- 31. Molecular Approaches to Developing a Vaccine for Leprosy,.- 32. Immunodiagnosis of Leprosy.- 33. Immunodiagnostic Approaches to the Detection of M. leprae Infection in Leprosy.- 34. Serological Survey of Leprosy Using a Monoclonal Antibody-Based Immunoassay and Phenolic Glycolipid ELISA.- IX Malaria and Leishmaniasis.- 35. Antisporozoite Malaria Vaccine Development Based on Circumsporozoite Protein.- 36. Malaria Sporozoite Vaccine Development: Recent Progress.- 37. Community-Based Integrated Vector Control of Malaria in India.- 38. Leishmaniasis and Malaria: New Tools for Epidemiological Analysis.- X New Approaches to Vaccinology.- 39. Vaccinia Virus Expression Vectors.- 40. Vaccinia Recombinants Expressing Foreign Antigens: Antiviral and Antitumor Immunity.- 41. Liposomes as Carriers of Vaccines.- 42. A Short Primer on Vaccine Design: Focus on the Interrelatedness of Antigenic Determinants Addressing Various Lymphocyte Sub-populations.- 43. Next Steps in the Evolution of Vaccinology.